Trials / Completed
CompletedNCT05071612
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 294 (actual)
- Sponsor
- Apnimed · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in Obstructive Sleep Apnea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD109 | Oral administration at bedtime |
| DRUG | AD504 | Oral administration at bedtime |
| DRUG | Atomoxetine Hydrochloride | Oral administration at bedtime |
| DRUG | Placebo | Oral administration at bedtime |
Timeline
- Start date
- 2021-11-29
- Primary completion
- 2022-07-20
- Completion
- 2022-08-03
- First posted
- 2021-10-08
- Last updated
- 2022-12-12
Locations
25 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05071612. Inclusion in this directory is not an endorsement.